Your browser doesn't support javascript.
loading
Navigating the Critical Translational Questions for Implementing FLASH in the Clinic.
Loo, Billy W; Verginadis, Ioannis I; Sørensen, Brita Singers; Mascia, Anthony E; Perentesis, John P; Koong, Albert C; Schüler, Emil; Rankin, Erinn B; Maxim, Peter G; Limoli, Charles L; Vozenin, Marie-Catherine.
Afiliación
  • Loo BW; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA. Electronic address: BWLoo@stanford.edu.
  • Verginadis II; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Sørensen BS; Danish Centre for Particle Therapy & Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Mascia AE; Division of Oncology, Cincinnati Children's Hospital and Departments of Pediatrics and Radiation Oncology, College of Medicine, University of Cincinnati, Cincinnati, OH.
  • Perentesis JP; Division of Oncology, Cincinnati Children's Hospital and Departments of Pediatrics and Radiation Oncology, College of Medicine, University of Cincinnati, Cincinnati, OH.
  • Koong AC; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Schüler E; Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Rankin EB; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA; Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA.
  • Maxim PG; Department of Radiation Oncology, University of California, Irvine School of Medicine, Irvine, CA.
  • Limoli CL; Department of Radiation Oncology, University of California, Irvine School of Medicine, Irvine, CA.
  • Vozenin MC; Secteur Radio-Oncologie et Radiobiologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland; LiRR - laboratory of innovation in radiobiology applied to radiotherapy, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Laboratory of Radiation Oncology, Radiation Oncology Service, Dep
Semin Radiat Oncol ; 34(3): 351-364, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38880544
ABSTRACT
The "FLASH effect" is an increased therapeutic index, that is, reduced normal tissue toxicity for a given degree of anti-cancer efficacy, produced by ultra-rapid irradiation delivered on time scales orders of magnitude shorter than currently conventional in the clinic for the same doses. This phenomenon has been observed in numerous preclinical in vivo tumor and normal tissue models. While the underlying biological mechanism(s) remain to be elucidated, a path to clinical implementation of FLASH can be paved by addressing several critical translational questions. Technological questions pertinent to each beam type (eg, electron, proton, photon) also dictate the logical progression of experimentation required to move forward in safe and decisive clinical trials. Here we review the available preclinical data pertaining to these questions and how they may inform strategies for FLASH cancer therapy clinical trials.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Investigación Biomédica Traslacional / Neoplasias Límite: Animals / Humans Idioma: En Revista: Semin Radiat Oncol Asunto de la revista: NEOPLASIAS / RADIOLOGIA Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Investigación Biomédica Traslacional / Neoplasias Límite: Animals / Humans Idioma: En Revista: Semin Radiat Oncol Asunto de la revista: NEOPLASIAS / RADIOLOGIA Año: 2024 Tipo del documento: Article